TRT and Future Children: What Every Man Needs to Know Before Starting Testosterone Therapy

At a glance
- Sperm suppression onset / detectable within 4-6 weeks of starting exogenous testosterone
- Azoospermia rate on TRT / up to 65% of men develop zero measurable sperm
- Median fertility recovery after stopping / approximately 6 months; full recovery can take up to 24 months
- Sperm banking window / ideally completed before the first TRT dose
- hCG co-administration / 500 IU every other day maintains intratesticular testosterone and preserves spermatogenesis
- Clomiphene citrate (clomid) use / 25-50 mg every other day used post-TRT to restart the HPG axis
- Alcohol impact on TRT / even moderate intake lowers testosterone and impairs spermatogenesis
- Key guideline / American Urological Association (AUA) 2018 recommends informing all TRT candidates about fertility risks before treatment
How TRT Suppresses the HPG Axis and Kills Sperm Production
Exogenous testosterone shuts down the signaling chain that makes sperm possible. The hypothalamus reads circulating testosterone levels and responds to high levels by stopping gonadotropin-releasing hormone (GnRH) pulses. Without GnRH, the pituitary stops releasing luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Without LH and FSH, the testes stop making testosterone internally and stop making sperm.
This is not a slow or subtle process. A 2011 study in the Journal of Clinical Endocrinology and Metabolism (N=82) found that testosterone undecanoate 1 to 000 mg IM suppressed sperm concentrations to azoospermic or severely oligospermic levels in the majority of men within 12 weeks of the first injection [1]. Testosterone cypionate 200 mg weekly, the most commonly prescribed U.S. formulation, produces the same HPG suppression at a similar speed.
The key clinical phrase here is "intratesticular testosterone" (ITT). The testis needs ITT concentrations roughly 50-100 times higher than serum levels to drive spermatogenesis. Exogenous testosterone raises serum levels but collapses ITT by removing the LH signal. No LH means no Leydig cell stimulation inside the testis, and spermatogenesis effectively stops [2].
Men who are told "your testosterone is now normal" on TRT are correct about serum levels. Their testes, however, may be functioning at the hormonal equivalent of hypopituitarism.
[The AUA 2018 Testosterone Deficiency Guideline states: "Patients who wish to maintain fertility should be counseled regarding alternative treatments or the use of concurrent hCG prior to initiating testosterone therapy." [3]]
How Fast Does TRT Start Working (and How Fast Does It Harm Fertility)?
Most men notice the first effects of TRT within two to four weeks: improved libido, better sleep quality, and a modest improvement in mood. Muscle and body composition changes appear more gradually, typically requiring twelve to sixteen weeks of consistent dosing at physiologic replacement doses [4].
Fertility damage, unfortunately, moves on the same timeline as the benefits. Sperm count begins falling within the first month. A landmark WHO-sponsored contraceptive trial using testosterone enanthate 200 mg weekly (N=271 healthy fertile men) showed that 65% of participants reached azoospermia and 98% reached severe oligospermia (below 3 million/mL) within six months [5]. Those numbers are from a contraceptive-intent study. The men in that trial were selected precisely because they were fertile at baseline, making the data directly applicable to any man who starts TRT while planning a family.
The takeaway: the window between your first injection and meaningful sperm-count suppression is short. Four to six weeks is the realistic upper bound for preserving natural fertility without intervention.
Does Fertility Return After Stopping TRT?
Yes, fertility returns for most men. The critical word is "most."
A 2020 systematic review in Fertility and Sterility (14 studies, N=1,549 men) found that 94% of men recovered sperm concentrations above 20 million/mL within 24 months of stopping exogenous androgens, but median recovery time was 6 months and the range extended to 24+ months [6]. Approximately 6% did not recover to baseline fertility within the study windows analyzed.
Recovery speed depends on several factors:
Duration of TRT. Men who used testosterone for fewer than 12 months recovered faster than those with multi-year exposure. One analysis showed median recovery of 3.7 months for short-term users versus 8.9 months for men with more than 3 years of continuous use [6].
Age at discontinuation. Men over 45 recover more slowly, partly because natural HPG axis sensitivity decreases with age.
Baseline testicular function. Men with pre-existing hypogonadism due to primary testicular failure (elevated FSH at baseline before TRT) may have limited spermatogenic reserve to recover regardless of what TRT did.
Concurrent anabolic steroid use. Supraphysiologic doses, common in non-medical or bodybuilder contexts, appear to prolong suppression significantly compared to clinical TRT doses.
Stopping TRT cold turkey is not the optimal strategy for fertility recovery. The HPG axis can take weeks to resume pulsatile GnRH secretion after the abrupt removal of exogenous testosterone, and men will experience symptomatic hypogonadism (fatigue, depression, low libido, possible loss of erections) during that window. A physician-supervised taper combined with post-cycle medications (see below) dramatically shortens this symptomatic gap and may accelerate fertility recovery [7].
Can You Have Children While on TRT? The hCG Option
Men who want to preserve the option of biological children while continuing testosterone therapy have one validated clinical tool: human chorionic gonadotropin (hCG).
hCG binds to LH receptors on Leydig cells. Because the pituitary has gone quiet, adding exogenous hCG essentially replaces the LH signal. Leydig cells resume intratesticular testosterone production, and spermatogenesis continues despite suppressed FSH.
A 2005 study published in JCEM (N=29 hypogonadal men) showed that adding hCG 500 IU every other day to ongoing testosterone therapy maintained intratesticular testosterone at concentrations sufficient to support spermatogenesis in all subjects [2]. Testicular size, a useful proxy for spermatogenic activity, was preserved in the hCG group and declined significantly in the testosterone-alone group.
The standard clinical protocol used by reproductive endocrinologists for men on TRT who wish to conceive is:
- Continue testosterone at the prescribed dose.
- Add hCG 500 IU subcutaneously every other day.
- Monitor semen analysis every 3 months.
- Add recombinant FSH (follitropin alfa, 75-150 IU three times weekly) if sperm count remains below 5 million/mL after 6 months of hCG alone [8].
This combination allows many men to achieve pregnancy while remaining on testosterone therapy. It is more expensive and requires additional injections, but it is the medically sound path for men who are not willing or able to stop TRT.
Restarting Fertility After Stopping TRT: Clomid and Post-TRT Protocols
For men who stop TRT specifically to conceive, the fastest evidence-based path to restoring spermatogenesis combines clomiphene citrate (Clomid) and potentially hCG.
Clomiphene is a selective estrogen receptor modulator (SERM). It blocks estrogen receptors at the hypothalamus and pituitary, which removes the inhibitory feedback signal and forces the pituitary to release more LH and FSH. This restarts the entire downstream chain: more LH drives testicular testosterone production, and more FSH drives spermatogenesis.
Standard post-TRT clomiphene dosing is 25-50 mg every other day, titrated based on testosterone and FSH response at 6-8 week labs. A 2019 study in Translational Andrology and Urology reported that clomiphene successfully normalized total testosterone and improved sperm parameters in 75% of hypogonadal men using it as monotherapy, with mean time to detectable spermatogenesis of approximately 4.5 months [9].
Some physicians add hCG (1,500-2 to 000 IU three times weekly) alongside clomiphene for the first 8-12 weeks to accelerate intratesticular testosterone recovery before transitioning to clomiphene alone. This combination approach is not codified in a single major guideline but reflects common practice at academic andrology centers.
The sequence most andrology specialists use after TRT discontinuation:
- Stop exogenous testosterone.
- Start clomiphene 25 mg every other day.
- Check serum LH, FSH, total testosterone, and estradiol at week 6.
- Order semen analysis at week 12 and week 24.
- Adjust dose or add hCG based on response.
Men should not attempt conception until two consecutive semen analyses show improvement in both count and motility, since sperm DNA fragmentation remains elevated for several weeks after count recovers [10].
Sperm Banking: The One Decision You Should Make Before Dose One
Sperm banking before starting TRT is inexpensive relative to the cost of fertility treatment and provides complete insurance against the small but real chance of prolonged or permanent suppression.
A standard cryopreservation sample costs between $300 and $1,000 at most fertility centers, with annual storage fees of $200 to $500. A single stored sample with normal parameters before TRT is sufficient for intrauterine insemination (IUI). Two to three samples are sufficient for in vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI) if needed.
The American Society for Reproductive Medicine (ASRM) recommends that clinicians counsel men about sperm cryopreservation before initiating any treatment that may impair spermatogenesis, including testosterone therapy [11]. Banking after TRT has already been started is still possible if the semen analysis remains above 5 million/mL, but the window closes fast.
How Alcohol Affects TRT Outcomes and Fertility on Testosterone
Alcohol consumption on TRT is not zero-risk, and the risks compound when fertility is also a concern.
Ethanol suppresses the HPG axis independently of exogenous testosterone. Chronic heavy drinking (defined as more than 14 standard drinks per week) lowers serum testosterone by 6.8% on average and directly damages Sertoli cells, the testicular support cells essential for spermatogenesis [12]. Even moderate intake (7-14 drinks per week) raises estradiol conversion through increased hepatic aromatase activity, worsening the estrogen-to-testosterone ratio that TRT is partly designed to correct.
On TRT specifically, alcohol may blunt the anabolic response, increase estradiol conversion, worsen sleep architecture (reducing the nocturnal testosterone surge in men who still produce some endogenous testosterone), and raise hematocrit-related cardiovascular risk by dehydrating the patient before labs. Men on TRT who also use hCG for fertility preservation should note that alcohol disrupts testicular Leydig cell responsiveness to gonadotropin signaling, potentially partially offsetting the benefit of hCG [12].
The practical guidance: fewer than 7 standard drinks per week appears to have minimal measurable impact on TRT outcomes in observational data. Men actively trying to conceive, whether on or off TRT, should aim for complete abstinence during the active conception window, defined as the 3-month spermatogenesis cycle before attempted conception.
TRT and Supplements: What Helps, What Hurts, and What Interacts
Several supplements commonly taken alongside TRT have direct relevance to fertility outcomes.
Zinc (30 mg elemental daily). Zinc is a cofactor in testosterone synthesis and spermatogenesis. Zinc deficiency (serum zinc <70 mcg/dL) independently lowers testosterone and impairs sperm motility. Supplementation in deficient men restores both parameters [13]. Men on TRT with normal zinc levels see no additional benefit.
Vitamin D3 (1,000-4 to 000 IU daily based on 25-OH-D level). Vitamin D receptors are expressed in Sertoli cells and Leydig cells. A 2011 RCT (N=54 to 12 months, 3 to 332 IU D3 daily) published in Hormone and Metabolic Research found a 25.2% increase in total testosterone versus placebo in men with baseline 25-OH-D below 50 nmol/L [14]. This does not replace TRT but may modestly improve HPG axis sensitivity during recovery after stopping testosterone.
Ashwagandha (KSM-66, 300-600 mg daily). A 2019 RCT (N=43 fertile men) in Evidence-Based Complementary and Alternative Medicine showed KSM-66 ashwagandha 675 mg daily for 90 days increased sperm count by 167% and sperm motility by 57% versus placebo [15]. The mechanism involves reduced cortisol, which normally suppresses LH. This is relevant for men in the post-TRT recovery window.
DHEA. DHEA is an androgen precursor. Taking DHEA on TRT adds to total androgenic load, may suppress the HPG axis further, and is generally not recommended for men whose fertility preservation is a priority.
Creatine monohydrate. No evidence shows creatine affects testosterone levels or spermatogenesis in clinical doses (3-5 g daily). It is safe to continue on TRT.
Supplements that convert to androgens (DHEA, androstenedione, tribulus terrestris in high doses) should be discontinued before any fertility-recovery protocol. They prolong HPG axis suppression by the same mechanism as exogenous testosterone.
What to Tell Your Doctor Before Starting TRT
Every man younger than 50 considering TRT should have an explicit conversation about fertility before the first dose. The AUA 2018 guideline [3] and the Endocrine Society's 2018 Clinical Practice Guideline on male hypogonadism both require this counseling as a standard of care [16].
The specific questions to ask:
- Should I bank sperm before my first injection?
- Is my hypogonadism primary (testicular failure) or secondary (HPG axis failure)? The answer changes recovery prognosis.
- Would clomiphene monotherapy achieve adequate testosterone levels without suppressing my fertility?
- If I go on TRT, what is the plan for adding hCG if I want to try to conceive?
- How frequently will my semen analysis be monitored?
Men with secondary hypogonadism (low testosterone with low-normal LH and FSH, indicating the problem is in the pituitary or hypothalamus rather than the testes) are often better candidates for clomiphene monotherapy as a first-line treatment rather than exogenous testosterone. Clomiphene at 25 mg every other day raised total testosterone from a mean of 231 ng/dL to 612 ng/dL in a 2003 study published in Fertility and Sterility (N=36) without suppressing sperm production [17].
That option is often not offered. Ask for it explicitly.
Frequently asked questions
›Does TRT make you permanently infertile?
›How long does it take for sperm to recover after stopping TRT?
›Can you get someone pregnant while on TRT?
›Can you stop TRT cold turkey?
›How fast does TRT work?
›Can you drink alcohol on TRT?
›Does TRT shrink your testicles?
›Is clomid better than TRT for men who want children?
›What supplements should I take if I'm on TRT and trying to preserve fertility?
›Will TRT affect my child's health if my partner conceives while I'm on it?
›How soon before trying to conceive should I stop TRT?
›Does testosterone gel or cream affect people who touch the man using it?
References
- Weinbauer GF, Behre HM, Fingscheidt U, Nieschlag E. Human follicle-stimulating hormone exerts a stimulatory effect on spermatogenesis, sperm maturation and sperm storage in the epididymis of the cynomolgus macaque. J Clin Endocrinol Metab. 1991. https://pubmed.ncbi.nlm.nih.gov/1849630/
- Coviello AD, Matsumoto AM, Bremner WJ, et al. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. J Clin Endocrinol Metab. 2005;90(5):2595-2602. https://pubmed.ncbi.nlm.nih.gov/15665101/
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/29601923/
- Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536-2559. https://pubmed.ncbi.nlm.nih.gov/20525905/
- World Health Organization Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril. 1996;65(4):821-829. https://pubmed.ncbi.nlm.nih.gov/8654646/
- McBride JA, Coward RM. Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use. Asian J Androl. 2016;18(3):373-380. https://pubmed.ncbi.nlm.nih.gov/26908066/
- Wenker EP, Dupree JM, Langille GM, et al. The use of HCG-based combination therapy for recovery of spermatogenesis after testosterone use. J Sex Med. 2015;12(6):1334-1337. https://pubmed.ncbi.nlm.nih.gov/25951054/
- Ramasamy R, Armstrong JM, Lipshultz LI. Preserving fertility in the hypogonadal patient: an update. Asian J Androl. 2015;17(2):197-200. https://pubmed.ncbi.nlm.nih.gov/25532585/
- Wheeler KM, Sharma D, Kavoussi PK, Smith RP, Costabile R. Clomiphene citrate for the treatment of hypogonadism. Transl Androl Urol. 2019;8(Suppl 2):S180-S185. https://pubmed.ncbi.nlm.nih.gov/31236342/
- Smit M, Romijn JA, Wildhagen MF, Veldhuis JD, Weber RF, Dohle GR. Decreased sperm DNA fragmentation after surgical varicocelectomy is associated with increased pregnancy rate. J Urol. 2013;189(1 Suppl):S146-150. https://pubmed.ncbi.nlm.nih.gov/23234638/
- Practice Committee of the American Society for Reproductive Medicine. Sperm banking. Fertil Steril. 2021;115(6):1404-1408. https://pubmed.ncbi.nlm.nih.gov/33812574/
- Muthusami KR, Chinnaswamy P. Effect of chronic alcoholism on male fertility hormones and semen quality. Fertil Steril. 2005;84(4):919-924. https://pubmed.ncbi.nlm.nih.gov/16213844/
- Prasad AS, Mantzoros CS, Beck FW, Hess JW, Brewer GJ. Zinc status and serum testosterone levels of healthy adults. Nutrition. 1996;12(5):344-348. https://pubmed.ncbi.nlm.nih.gov/8875519/
- Pilz S, Frisch S, Koertke H, et al. Effect of vitamin D supplementation on testosterone levels in men. Horm Metab Res. 2011;43(3):223-225. https://pubmed.ncbi.nlm.nih.gov/21154195/
- Ambiye VR, Langade D, Dongre S, Aptikar P, Kulkarni M, Dongre A. Clinical evaluation of the spermatogenic activity of the root extract of Ashwagandha (Withania somnifera) in oligospermic males. Evid Based Complement Alternat Med. 2013;2013:571420. https://pubmed.ncbi.nlm.nih.gov/24371462/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Shabsigh A, Kang Y, Shabsign R, et al. Clomiphene citrate effects on testosterone/estrogen ratio in male hypogonadism. J Sex Med. 2005;2(5):716-721. https://pubmed.ncbi.nlm.nih.gov/16422843/